Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis.
Marco CaminatiElena ScarpieriMatteo MaulePatrick PinterMichele SchiappoliRachele VaiaGianenrico SennaPublished in: Rheumatology (Oxford, England) (2023)